PDF Publication Title:
Text from PDF Page: 015
Wei et al. Page 15 Drug Discov Today. Author manuscript; available in PMC 2016 May 01. Anticancer effect of AgNPsa Application Cells and/or organisms Size (nm) Surface stability Dose Exposure time Function Refs Antiangiogenesis BREC/female C57BL/6 mice DLA/female Swiss albino mice 40–50 50 None N/A IC50: 500 nM; injection: AgNPs (500 nM) 24 h for cell assay; injection for 7 days Inhibits formation of new [61] blood vessels Antileukemia AML cells 3,11, and 30 PVP-AgNPs 0–10 μg/mL 24 h 11-nm AgNPs have significant [46] inhibition effect with low IC50 (0.90 – 3.43 μg/mL) on six AML cells Antibreast cancer MCF-7 MDAMB-231 MDAMB-231 HepG2 NA 5 2–10 5–10 Grenetine-stabilized colloidal silver None N/A None LD50: 3.5 ng/mL IC50: 6.0 μg/mL IC50: 8.7 μg/mL IC50: 3.38 μg/mL 5h 24h 24h 28 h Dose-dependent cytotoxic [64] effect in MCF-7 cells Antihepatoma AgNPs exhibited cytotoxicity [22] with a potency comparable with that of Ag+ ions Antilung caner A549 H157 30–50 10–20 PVP-AgNPs AgNPs capped with table sugar 0–20 μg/mL IC50: 3.6 μM 24 h 48 h Reduction in mitochondrial [69] function K562 cells --- PVP-AgNPs ----- --- Enters K562 cells in a dose- [63] dependent manner and locates in endosomes HepG2 20 None 1–20 μg/mL 24 h Oxidative stress did not have [67] major role in observed cytotoxicity of AgNPs in HepG2 HepG2 and primary liver cells of mice 20–40 None IC50 2.764 μg/mL for HepG2 cell line and IC50 121.7 μg/mL for primary liver cells of mice 24 h 44 times stronger inhibitory [68] effect on growth of HepG2 cell line compared with normal cells Table 2 IC50: 500 nM; intraperitoneal 24 h for MTT assay; injection of AgNPs for 15 days Increased survival time, [62] decreased volume of ascitic fluid in tumor-bearing mice by 65%, returning body weight to injection: AgNPs (500 nM) normal Inhibits cell viability and [65] induces membrane leakage Inhibit the growth of cells in a [66] dose-dependent manner Remarkable inhibition on [70] H157 Author Manuscript Author Manuscript Author Manuscript Author ManuscriptPDF Image | Silver nanoparticles: synthesis, properties, therapeutic apps
PDF Search Title:
Silver nanoparticles: synthesis, properties, therapeutic appsOriginal File Name Searched:
nihms651778.pdfDIY PDF Search: Google It | Yahoo | Bing
Turbine and System Plans CAD CAM: Special for this month, any plans are $10,000 for complete Cad/Cam blueprints. License is for one build. Try before you buy a production license. More Info
Waste Heat Power Technology: Organic Rankine Cycle uses waste heat to make electricity, shaft horsepower and cooling. More Info
All Turbine and System Products: Infinity Turbine ORD systems, turbine generator sets, build plans and more to use your waste heat from 30C to 100C. More Info
CO2 Phase Change Demonstrator: CO2 goes supercritical at 30 C. This is a experimental platform which you can use to demonstrate phase change with low heat. Includes integration area for small CO2 turbine, static generator, and more. This can also be used for a GTL Gas to Liquids experimental platform. More Info
Introducing the Infinity Turbine Products Infinity Turbine develops and builds systems for making power from waste heat. It also is working on innovative strategies for storing, making, and deploying energy. More Info
Need Strategy? Use our Consulting and analyst services Infinity Turbine LLC is pleased to announce its consulting and analyst services. We have worked in the renewable energy industry as a researcher, developing sales and markets, along with may inventions and innovations. More Info
Made in USA with Global Energy Millennial Web Engine These pages were made with the Global Energy Web PDF Engine using Filemaker (Claris) software.
Infinity Turbine Developing Spinning Disc Reactor SDR or Spinning Disc Reactors reduce processing time for liquid production of Silver Nanoparticles.
CONTACT TEL: 608-238-6001 Email: greg@infinityturbine.com (Standard Web Page)